The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis

被引:0
|
作者
Arif Ülkü Yener
Kubilay Şahin
机构
[1] Keçiören Training and Research Hospital,Department of Ophthalmology
[2] Keçiören Training and Research Hospital,Department of Rheumatology
来源
关键词
Rheumatoid arthritis; Choroidal thickness; Optical coherence tomography angiography; Rheumatoid factor; Anti-cyclic citrullinated peptide antibody;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:935 / 941
页数:6
相关论文
共 50 条
  • [21] Clinical Significance of Anti-Cyclic Citrullinated Peptide Antibodies and IgM Rheumatoid Factor in Rheumatoid Arthritis Patients
    Seo, Soyeon
    Lee, Jisoo
    Kang, Eun-Suk
    EWHA MEDICAL JOURNAL, 2005, 28 (02): : 87 - 92
  • [22] Serum markers of rheumatoid arthritis in visceral leishmaniasis:: Rheumatoid factor and anti-cyclic citrullinated peptide antibody
    Atta, A. M.
    Carvalho, E. M.
    Jeronimo, S. M. B.
    Atta, M. L. B. Sousa
    JOURNAL OF AUTOIMMUNITY, 2007, 28 (01) : 55 - 58
  • [23] Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
    Devesh Mewar
    Annabel Coote
    David J Moore
    Ioanna Marinou
    Jodie Keyworth
    Marion C Dickson
    Doug S Montgomery
    Michael H Binks
    Anthony G Wilson
    Arthritis Research & Therapy, 8
  • [24] Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis
    Mikuls, Ted R.
    Holers, V. Michael
    Parrish, Lezlie
    Kuhn, Kristine A.
    Conn, Doyt L.
    Gilkeson, Gary
    Smith, Edwin A.
    Kamen, Diane L.
    Jonas, Beth L.
    Callahan, Leigh F.
    Alarcon, Graciela S.
    Howard, George
    Moreland, Larry W.
    Bridges, S. Louis, Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 3057 - 3059
  • [25] Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis
    van Oosterhout, M.
    Bajema, I.
    Levarht, E. W. N.
    Toes, R. E. M.
    Huizinga, T. W. J.
    van Laar, J. M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 53 - 60
  • [26] Bleeding in Rheumatoid Arthritis: Association Between Hypofibrinogenemia and Anti-cyclic Citrullinated Peptide Antibodies?
    Fernandez-Mosteirin, N.
    Calvo Villas, J. M.
    HAEMOPHILIA, 2017, 23 : 111 - 111
  • [27] Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis
    Gerli, R.
    Bocci, E. Bartoloni
    Sherer, Y.
    Vaudo, G.
    Moscatelli, S.
    Shoenfeld, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) : 724 - +
  • [28] Differentiation of Rheumatoid Arthritis From HCV Infection: Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide or Anti-Mutated Citrullinated Vimentin?
    Kaptanoglu, Ece
    Nadir, Isilay
    Bakici, Zahir
    Hayta, Emrullah
    Turkmen, Mehmet
    Sezer, Hafize
    Hizmetli, Sami
    Elden, Hasan
    TURKISH JOURNAL OF RHEUMATOLOGY, 2010, 25 (01) : 19 - 23
  • [29] THE DIAGNOSTIC UTILITY OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN RHEUMATOID ARTHRITIS
    Eldin, A. Radr
    Mobasher, S. A.
    Hegazy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 898 - 898
  • [30] Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Mofidi, Mani
    Moghadam, Afshin
    SAUDI MEDICAL JOURNAL, 2008, 29 (08) : 1206 - 1207